SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as market participants weigh strong revenue growth against a significant miss on earnings and profitability, fueled by concerns over heavy capital expenditure on AI and robotics. Community discussions are sharply divided, with bulls highlighting the long-term potential of FSD, Robotaxi, and Optimus, while bears cite margin erosion and skepticism regarding management's aggressive timelines.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending after reporting a double earnings beat and raised full-year guidance, with investors focusing on the company's strong AI product adoption as a rebuttal to bearish 'SaaS apocalypse' narratives. While some traders are expressing frustration over muted stock reactions and options market volatility, the community is actively debating the transition toward non-seat-based AI pricing models and ServiceNow's long-term potential as an enterprise AI control layer.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending after reporting a significant earnings beat and massive cloud revenue growth, with community discussion intensely focused on whether the company's aggressive and increasing AI-related capital expenditures will yield long-term ROI or create near-term margin pressure. Investors remain divided, with many celebrating the strong cloud backlog and Gemini adoption, while others are cautious about the impact of persistent high spending and ongoing supply constraints on the stock's immediate direction.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors closely monitor earnings and capital expenditure (CapEx) updates, weighing the potential for sustained AI-driven cloud growth against concerns over aggressive spending and its impact on free cash flow. The community is actively debating whether these heavy investments represent a strategic foundation for long-term AI dominance or a short-term risk to profitability.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors aggressively position themselves ahead of the upcoming earnings release, with a mix of high-conviction buying and hedging activity driving significant options flow. The community is heavily focused on whether the company's AI-RAN partnership with Nvidia and recent infrastructure developments can translate into growth that validates its long-term potential as a critical AI hardware supplier.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is currently facing heightened volatility and selling pressure as investors await the upcoming earnings call, with the community actively debating whether the stock's recent decline to new lows is a major red flag or an accumulation opportunity. Investors are fixated on potential manufacturing updates, the timeline for commercialization, and the significance of recent partnership developments, while sentiment remains deeply polarized between long-term holders citing technological potential and vocal bears focusing on the lack of revenue and the pace of progress.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly anticipate upcoming Phase 3 IZAR-1 trial results, which the community views as a critical catalyst for validating the drug's potential as a best-in-class treatment. Market sentiment is heavily focused on the stock's platform potential and the prospect of a major pharmaceutical acquisition, with participants actively debating insider trading patterns and the impact of recent clinical data on the company's valuation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to heightened geopolitical tensions in the Middle East, specifically escalating conflict in the Strait of Hormuz and reports of attacks on energy infrastructure. Community members are actively debating the potential for supply-side shocks and inflationary impacts, with many traders closely monitoring military developments and official statements for signals of future volatility.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors closely monitor its aggressive AI infrastructure spending and capital expenditure plans ahead of earnings. Community discussion highlights a debate between those viewing the heavy investment in data centers and cloud capacity as a necessary catalyst for long-term growth and those expressing concern over short-term impacts on margins and stock price performance.

Shutterstock, Inc. engages in the provision of a global creative platform. The company offers data, distribution, and services. Its contents include images, footage, music, three dimensional (3D) models, and generative artificial intelligence. The company was founded by Jonathan Evan Oringer in 2003 and is headquartered in New York, NY.

Shutterstock Inc

Shutterstock is experiencing significant volatility and negative sentiment as investors react to the company's decision to suspend its quarterly dividend. While some community members remain optimistic about the long-term potential of its AI-driven data training revenue, others are speculating that the stock's depressed price makes it a prime target for a private equity takeover.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy

Tarsus Pharmaceuticals (TARS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?

Tarsus Pharmaceuticals (TARS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

TARS Stock Drops After Culper Research Accuses Tarsus Of Illegal Medicare Copay Scheme

Equity

Culper’s central allegation is that Tarsus has driven XDEMVY uptake among Medicare patients by funding copay assistance. 


Tarsus Pharmaceuticals Stock Drops as Short Seller Alleges Illegal Copay Scheme

Tarsus Pharmaceuticals Inc (NASDAQ:TARS) shares are falling Wednesday. Short-seller Culper Research published a report Wednesday alleging the company's sole commercial product relies on an illegal Medicare copay scheme. Here's what you should know.read more...

Ultragenyx (RARE) Soars 5.2%: Is Further Upside Left in the Stock?

Ultragenyx (RARE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?

Biogen (BIIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Noteworthy Friday Option Activity: TARS, LYV, RIOT

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tarsus Pharmaceuticals Inc (Symbol: TARS), where a total volume of 3,560 contracts has been traded thus far today, a contract volume which is representative of a...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of +64.91% and +9.64%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

HC Wainwright Issues Pessimistic Outlook for TARS Earnings

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) - Equities researchers at HC Wainwright decreased their Q1 2026 earnings per share estimates for shares of Tarsus Pharmaceuticals in a research note issued to investors on Monday, May 4th. HC Wainwright analyst M. Caufield now forecasts that t...

Tarsus Pharmaceuticals (NASDAQ:TARS) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $88.00 price objective on shares of Tarsus Pharmaceuticals in a research note on Monday...

Tarsus Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Tarsus Pharmaceuticals Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$57.58
Prev Close	$57.26
Open	$57.25
Dividend Yield	0.00%
50-Day Moving Average	$61.61
Beta	0.72
Avg. Volume	749,970.00
PE Ratio	-50.80

52-Week High	$85.25
52-Week Low	$38.51
Market Capitalization	$2.46B
EPS (Annual)	-$1.59
Price to Book	7.10
Revenue Per Employee	$1.22M

Feed

News

Sentiment

Earnings

Fundamentals

Info

TARSTarsus Pharmaceuticals Inc

Latest TARS News